Clinical assessment of efficacy of Omega 3 in Oral Submucous Fibrosis patients treated with intralesional steroid and hyaluronidase therapy Ã¢â?¬â??A randomized controlled trial.

Dr Milanjeet Kaur0 个研究点目标入组 48 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.patients who are more than 18 years in age
•2. Patients suffering from chronic oral submucous fibrosis lesions characterised by burning sensations in the mouth, particularly while taking hot and spicy food.
•3.Patients who are physically healthy & well oriented in time, space & as a person.
•4. Patients not on any treatment for the same. In case they are, then such treatment will be stopped & a wash out period of 2 weeks will be given
•5.Patients who will agree to whole examination, undergo treatment & will be willing for evaluation every month for 6 month & one year

•1.Patients suffering from any other systemic diseases like diabetes, Hypertension, Cardiovascular system disease, renal function, liver disorders etc.
•2.Patients with any other mucosal disease or any other skin lesions which may be associated with oral lesions
•3.Patients on any drug therapy.
•4.Patients with findings of any physical or mental abnormality which would interfere with or be affected by the study procedure.
•5.Patients with a known allergy or contraindication to study medications

发起方

Dr Milanjeet Kaur